Get started
Author

Candice R. Gurbatri

Observed names: C. Gurbatri, Candice Gurbatri, Gurbatri, Candice Robyn
ORCID: 0000-0002-1464-7089
Observed ORCID: 0000-0002-1464-7089
OpenAlex ID: A5063504151
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
2017 · Leore T. Geller, Michal Barzily-Rokni, et al. · Science · 1,878
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
2020 · Candice R. Gurbatri, Ioana Lia, et al. · Science Translational Medicine · 665
PDF
Engineering bacteria as interactive cancer therapies
2022 · Candice R. Gurbatri, Nicholas Arpaia, et al. · Science · 479
PDF
Probiotic-guided CAR-T cells for solid tumor targeting
2023 · Rosa L. Vincent, Candice R. Gurbatri, et al. · Science · 288
PDF
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 · Andrew Redenti, Jongwon Im, et al. · Nature · 231
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
2024 · Candice R. Gurbatri, Georgette A. Radford, et al. · Nature Communications · 224
PDF
Abstract 6248: Engineered probiotics for local delivery of checkpoint blockade nanobodies
2020 · Candice Gurbatri, Ioana Lia, et al. · Cancer Research · 4
Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies
2023 · Candice Gurbatri, Tal Danino · Methods in molecular biology · 3
Abstract 5237: Engineered probiotics direct the antigen specificity of CAR-T cells in situ
2024 · Rosa L. Vincent, Fangda Li, et al. · Cancer Research · 2
GEMINI-NSCLC: Multiomics and single-cell spatial profiling to benchmark, back-translate, and build digital twins of IO response.
2026 · Vincent Perez, Candice Gurbatri, et al. · Journal of Clinical Oncology
RWD113 Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study
2025 · Candice R. Gurbatri, Kathleen Burke, et al. · Value in Health
EP.07D.05 Molecular Testing Care Gap Analysis of EGFR Mutation for Early-Stage NSCLC Patients in Community Practices
2024 · J. Dow, N. Zimmerman, et al. · Journal of Thoracic Oncology
PDF
Abstract 6525: Colon cancer screening and treatment with engineered probiotics
2023 · Candice R. Gurbatri, Georgette Radford, et al. · Cancer Research
Programmable Bacteria: An Emerging Therapeutic
2017 · Candice Gurbatri, Tetsuhiro Harimoto, et al. · The MIT Press eBooks
Works count: 15
Citation count: 3,774
H-index: 6
I10-index: 6
Year
Topic
Type